Delivery Order SPE2DB20D1109-SPE2DB25FP53V
Award Date 8/7/25
Potential Completion Date 8/28/25
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $10,941.84 for XEOMIN 50 unit vials, a botulinum toxin product used for therapeutic and cosmetic purposes. The contract, designated as firm fixed price with no set-aside, was awarded on September 18, 2025, with an ultimate completion date of October 9, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $16,762.20 to AmerisourceBergen Drug Corp for XEOMIN 200 Unit Vials, a botulinum toxin product used for medical purposes. This firm fixed price delivery order, issued on August 27, 2025, with an ultimate completion date of September 18, 2025, was competitively awarded without set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a leading pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of XEOMIN 200 Unit Vials, a botulinum toxin injection used primarily for therapeutic and cosmetic medical applications. This competitively awarded, non-set-aside contract is valued at $11,174.80 with a firm fixed price structure and an ultimate completion date of September 17, 2025. The product will be performed at AmerisourceBergen's corporate headquarters location in...
- The Defense Logistics Agency awarded a $26,819.52 delivery order to AmerisourceBergen Drug Corp for 200 unit vials of XEOMIN, a botulinum toxin product used for therapeutic and cosmetic medical applications. Issued on August 19, 2025, with an ultimate completion date of September 10, 2025, this firm fixed-price contract represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $5,587.40 to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN, a botulinum toxin product used for medical and therapeutic purposes. This competitive award, issued on August 22, 2025, with an ultimate completion date of September 15, 2025, carries firm fixed pricing and represents a non-set-aside contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,215.76 to AmerisourceBergen Drug Corp for XEOMIN 50U (botulinum toxin Type A), a pharmaceutical product used in medical and therapeutic applications. This firm fixed price delivery order, issued on August 29, 2025, with an ultimate completion date of September 19, 2025, represents a non-competitive award issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical....
- The Defense Logistics Agency awarded a $16,762.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of XEOMIN, a botulinum toxin preparation used for therapeutic and cosmetic medical applications. This non-competitive delivery order, issued on June 2, 2025, with completion expected by June 24, 2025, will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,352.44 delivery order to AmerisourceBergen Drug Corp for 200-unit vials of XEOMIN, a botulinum toxin-based therapeutic product commonly used for medical and cosmetic purposes. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for...
- The Defense Logistics Agency awarded a $12,851.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Xeomin, a botulinum toxin product used for therapeutic and cosmetic medical applications. The contract, awarded on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX). The company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN, a botulinum toxin product used for medical and therapeutic purposes, valued at $42,642.60. This firm fixed-price delivery order, awarded on September 25, 2025, with an ultimate completion date of October 17, 2025, was competitively awarded without set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a...